Merck Research and Development Expenses 2012-2026 | MRK

Merck research and development expenses for the twelve months ending March 31, 2026 were $24.760B, a 40.95% increase year-over-year.

  • Merck annual research and development expenses for 2025 were $15.789B, a 11.98% decline from 2024.
  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.

Merck Research and Development Expenses 2012-2026 | MRK

  • Merck annual research and development expenses for 2025 were $15.789B, a 11.98% decline from 2024.
  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B